Posted by Michael Wonder on 28 Apr 2025
First treatment against severe thyroid eye disease
25 April 2025 - Tepezza significantly improves symptoms for patients with moderate to severe thyroid eye disease
The EMA has recommended granting a marketing authorisation in the European Union for Tepezza (teprotumumab), for the treatment of adults with moderate to severe thyroid eye disease.
